A team of researchers at the University of New Mexico (UNM) and the National Institutes of Health (NIH) have developed a vaccine to treat high cholesterol. The vaccine, which targets a molecule called PCSK9, a protein involved in cholesterol metabolism, is a cost-effective alternative to current expensive cholesterol drugs and could lead to a widely applicable vaccine-based approach for controlling high cholesterol and cardiovascular disease.
The study demonstrated that the vaccine dramatically lowered cholesterol levels in animals. The study, “A Cholesterol-Lowering VLP Vaccine that Targets PCSK9,” was recently published in the journal Vaccineby Dr. Bryce Chackerian, professor in the Department of Molecular Genetics & Microbiology at UNM, Erin Crossey, an MD/Ph.D. student at UNM, and Drs. Alan Remaley, John Schiller and Marcelo Amar at NIH.
Genetic mutations that increase PCSK9 activity are linked to increased levels of low-density lipoprotein cholesterol (LDL-C—the “bad” cholesterol), which in turn is associated with an increased risk of plaque build-up in the arteries leading to coronary heart disease (CHD) and stroke. More than 73 million adults in the United States (approximately 32 percent of the population) have elevated LDL-C levels, or high cholesterol.
Although lifestyle changes and medication (such as statins) can lower LDL-C, more than 60 percent of at-risk patients on lipid lowering therapy still go on to have a cardiovascular event.
Statins have side effects, including increased concentrations of liver enzymes, muscle pain, cognitive loss, increased risk of diabetes, and adverse drug interactions. As an alternative to statins, drug companies have developed monoclonal antibody-based drugs that target PCSK9, such as Alirocumab and Evolocumab that were recently approved by the FDA to treat high cholesterol.
While these drugs have been shown to dramatically reduce LDL-C levels (by up to 60 percent) and cardiovascular events, they are extremely expensive, costing over $10,000 per year. This will likely limit the use of this class of drugs for those patients who cannot be effectively managed with statins or some of the other currently used cholesterol-lowering drugs. Additionally, monoclonal antibody therapies must be administered repeatedly for therapeutic effect.
The vaccine uses a VLP (virus-like particle) technology developed by Dr. Chackerian and his UNM co-inventors as an immunogenic carrier of an antigenic PCSK9 peptide. VLP’s are viruses that have had their DNA removed so that they retain their external structure for antigen display but are unable to replicate; they can induce an immune response without causing infection. VLP based vaccines are effective and safe and can be developed rapidly at low cost.
In the study, mice and macaques vaccinated with bacteriophage VLPs displaying PCSK9-derived peptides developed high titer IgG antibodies that bound to circulating PCSK9. Vaccination was associated with significant reductions in total cholesterol, free cholesterol, phospholipids, and triglycerides.
“We believe that this vaccine could lead to a widely applicable approach for controlling hypercholesteremia and cardiovascular disease,” Chackerian said.
Read more: UNM, NIH researchers develop vaccine to treat high cholesterol
The Latest on: High cholesterol
via Google News
The Latest on: High cholesterol
- How to live longer: Kalonji shown to lower cholesterol and blood sugar - what is it?on November 17, 2020 at 6:07 am
You can never predict nor prevent the challenges life will throw at you but you can make sure you are in the best possible situation to deal with them when they come knocking. Kalonji has been shown ...
- 90% of People with Type 2 Diabetes Had High Risk for Heart Attack, Study Findson November 16, 2020 at 4:33 pm
Researchers found over 90 percent of patients with type 2 diabetes have a high risk of fatal heart disease or stroke within 10 years.
- Individuals with high BMI and LDL cholesterol are at increased risk of COVID-19on November 16, 2020 at 6:15 am
A new study led by researchers at Queen Mary University of London uses a novel approach to investigate the effects of cardiovascular risk factors on the risk of COVID-19 infection.
- Experimental drug halves cholesterol levels in phase 2 clinical trialson November 15, 2020 at 6:48 pm
Scientists are reporting promising results from a phase 2 clinical trial of a cholesterol-reducing drug called evinacumab. The study reports that in patients with extremely high cholesterol, the drug ...
- A novel monoclonal antibody therapy cuts LDL cholesterol by half in a high-risk patient population,on November 15, 2020 at 7:49 am
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called ''bad'' cholesterol--by 50 percent in patients with severe hypercholesterolemia whose condition is ...
- High cholesterol: Sterols and stanols can reduce ‘bad’ cholesterol - what are they?on November 14, 2020 at 1:49 pm
HIGH cholesterol is a health hazard; low-density lipoprotein (LDL) is known as the 'bad' waxy substance that puts your life in jeopardy. However, sterols and stanols can help reduce cholesterol from ...
- 400+ clinics achieve recognition in patient-centric cholesterol programon November 12, 2020 at 8:45 am
The American Heart Association is recognizing 428 outpatient clinics for efforts surrounding cholesterol education and management for patients out of 1,300 participating organizations nationwide. The ...
- 15 Worst Foods for High Cholesterolon November 5, 2020 at 1:18 pm
Refined carbohydrates, vegetable oils, and saturated fats are among the worst foods for high cholesterol. Dietitians highlight the specific eats to avoid.
- Ask the Expert: The Genetics of Inherited High Cholesterolon October 26, 2020 at 10:33 am
There are many ways that cholesterol production can be changed by genetic mutations, including: increased low-density lipoprotein (LDL) decreased high-density lipoprotein (HDL) increased ...
- Eggs and cholesterol: Why you shouldn't worry about having eggs for breakfaston October 21, 2020 at 2:11 pm
Certain foods can contribute to plaque buildup in your arteries, causing atherosclerosis and potentially leading to high cholesterol or serious heart problems. While it's common to limit foods ...
via Bing News